Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for the inhibition of epstein-barr virus transmission employing anti-viral peptides capable of abrogating viral fusion and transmission

Methods for the inhibition of epstein-barr virus transmission employing anti-viral peptides capable of abrogating viral fusion and transmission

US Patent 6518013 · Granted Feb 11, 2003

Estimated economic value: $10,620,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Recombinant plasmin for opthalmic indications2012
Isolated peptides derived from human immunodeficiency virus types 1 and 2 contai2010
Isolated peptides derived from human immunodeficiency virus types 1 and 2 contai2010
Isolated peptides derived from human immunodeficiency virus types 1 and 2 contai2010
Methods for inhibition of membrane-fusion-associated events, including Hepatitis2009
Methods for inhibition of membrane-fusion-associated events, including Hepatitis2009
Methods for inhibition of membrane-fusion-associated events, including Hepatitis2009
DNA encoding T-1249 and other viral fusion inhibitor peptides useful for treatin2007
DNA encoding T-1249 and other viral fusion inhibitor peptides useful for treatin2007
Fusion proteins comprising DP-178 and other viral fusion inhibitor peptides usef2006
Fusion proteins comprising DP-178 and other viral fusion inhibitor peptides usef2006
Fusion proteins comprising DP-178 and other viral fusion inhibitor peptides usef2006